These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34922421)

  • 21. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
    Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
    Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
    Heo E; Kim E; Jang EJ; Lee CH
    BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study.
    Vajravelu ME; Hitt TA; Amaral S; Levitt Katz LE; Lee JM; Kelly A
    Pediatr Diabetes; 2021 Sep; 22(6):861-871. PubMed ID: 33978986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.
    Beckmann K; Crawley D; Nordström T; Aly M; Olsson H; Lantz A; Binti Abd Jalal N; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
    JAMA Netw Open; 2019 Nov; 2(11):e1914689. PubMed ID: 31693126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea.
    Cho YY; Kang MJ; Kim SK; Jung JH; Hahm JR; Kim TH; Nam JY; Lee BW; Lee YH; Chung JH; Song SO; Kim SW
    Thyroid; 2018 Jul; 28(7):864-870. PubMed ID: 29808777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
    Barner JC
    Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database.
    Kim J; Hyun HJ; Choi EA; Kim Y; Bae YJ; Kang HT
    Gastric Cancer; 2020 Nov; 23(6):1075-1083. PubMed ID: 32462322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.
    Chang YC; Chuang LM; Lin JW; Chen ST; Lai MS; Chang CH
    Diabet Med; 2015 Nov; 32(11):1460-9. PubMed ID: 25970814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and primary bone cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Bone; 2021 Oct; 151():116037. PubMed ID: 34116220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
    Smiechowski BB; Azoulay L; Yin H; Pollak MN; Suissa S
    Diabetes Care; 2013 Jan; 36(1):124-9. PubMed ID: 22923670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
    Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus.
    Eurich DT; Simpson SH; Majumdar SR; Johnson JA
    Pharmacotherapy; 2005 Jun; 25(6):810-6. PubMed ID: 15927899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating Metformin Strategies for Cancer Prevention: A Target Trial Emulation Using Electronic Health Records.
    Dickerman BA; García-Albéniz X; Logan RW; Denaxas S; Hernán MA
    Epidemiology; 2023 Sep; 34(5):690-699. PubMed ID: 37227368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin therapy and hip fracture risk among patients with type II diabetes mellitus: A population-based cohort study.
    Oh TK; Song IA
    Bone; 2020 Jun; 135():115325. PubMed ID: 32201359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019.
    Sun JW; Hernández-Díaz S; Bourgeois FT; Haneuse S; Brill G; Bateman BT; Huybrechts KF
    Diabetes Obes Metab; 2021 Feb; 23(2):444-454. PubMed ID: 33118291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.